Cytek Biosciences (CTKB) Tax Provisions (2020 - 2026)

Cytek Biosciences (CTKB) has 7 years of Tax Provisions data on file, last reported at $1.5 million in Q1 2026.

• For the quarter ending Q1 2026, Tax Provisions rose 1400.0% year-over-year to $1.5 million; the trailing twelve-month figure through Mar 2026 stood at $38.1 million (up 1096.92% YoY), and the FY2025 full-year result was $36.7 million, up 11368.12% from the prior year.
• Tax Provisions for Q1 2026 stood at $1.5 million, down from $40.0 million in the prior quarter.
• Across five years, Tax Provisions topped out at $40.0 million in Q4 2025 and bottomed at -$2.8 million in Q1 2024.
• The 5-year median for Tax Provisions is -$699000.0 (2022), against an average of $2.0 million.
• The widest annual swing landed in 2022, when Tax Provisions slumped 2390.0%; it then surged 5788.97% in 2025.
• A 5-year view of Tax Provisions shows it stood at $396000.0 in 2022, then plunged by 443.69% to -$1.4 million in 2023, then jumped by 149.96% to $680000.0 in 2024, then soared by 5788.97% to $40.0 million in 2025, then sank by 96.25% to $1.5 million in 2026.
• The last three Tax Provisions figures came in at $1.5 million (Q1 2026), $40.0 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.

Peer Comparison